Company intelligence / Profile preview
Saccoo
- Ownership
- Private
- Employees
- ~450
- Development stage
- Other
Overview
Sacco System is an international biotech hub focused on the research, development, and production of microbial cultures, probiotics, and enzymes. The company operates as a specialized CDMO and ingredients provider for the pharmaceutical, nutraceutical, and food industries, with a significant emphasis on the human microbiome. Their expertise spans from strain selection and characterization to large-scale industrial fermentation and freeze-drying. Sacco System provides clinically documented probiotic strains for applications in gastrointestinal health, dermatology, and immune modulation.
- Therapeutic areas
- GastroenterologyWomen's HealthDermatologyImmunology
- Modalities
- Live biotherapeutic product therapyBiologicMicrobial therapy
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Saccoo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saccoo.